PMID: 2110366May 1, 1990Paper

Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1

Proceedings of the National Academy of Sciences of the United States of America
E MadisonR Bassel-Duby

Abstract

Fibrinolysis is regulated in part by the interaction between tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1, a serine protease inhibitor of the serpin family). It is known from our earlier work that deletion of a loop of amino acids (residues 296-302) from the serine protease domain of t-PA suppresses the interaction between the two proteins without altering the reactivity of t-PA towards its substrate, plasminogen. To define more precisely the role of individual residues within this loop, we have used site-directed mutagenesis to replace Lys-296, Arg-298, and Arg-299 with negatively charged glutamic residues. Replacement of all three positively charged amino acids generates a variant of t-PA that associates inefficiently with PAI-1 and is highly resistant to inhibition by the serpin. Two t-PAs with point mutations (Arg-298----Glu and Arg-299----Glu) are partially resistant to inhibition by PAI-1 and associate with the serpin at intermediate rates. Other point mutations (Lys-296----Glu, His-297----Glu, and Pro-301----Gly) do not detectably affect the interaction of t-PA with PAI-1. None of these substitutions has a significant effect on the rate of catalysis by t-PA or on the affinity of t...Continue Reading

Citations

Nov 15, 1996·The Journal of Biological Chemistry·K Tachias, E L Madison
Aug 15, 1997·The Journal of Biological Chemistry·S H KeE L Madison
Dec 31, 1997·The Journal of Biological Chemistry·J J Perona, C S Craik
Sep 27, 2003·Blood·Taher NassarAbd Al-Roof Higazi
Aug 22, 2014·Molecular Biotechnology·Amirhossein SaadatiradFereidoun Mahboudi
Mar 9, 2019·Scientific Reports·Emilia M MarijanovicAshley M Buckle
Jan 16, 1992·Nature·J MottonenE J Goldsmith
Mar 1, 1995·Protein Science : a Publication of the Protein Society·J J Perona, C S Craik
Apr 7, 2000·Protein Science : a Publication of the Protein Society·A VindigniE Di Cera
Apr 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·David T BergBryan E Jones
Feb 21, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Sa'ed AkkawiAbd Al-Roof Higazi
Aug 29, 2006·Nature Neuroscience·William M ArmsteadAbd Al-Roof Higazi
Jan 12, 2007·The Journal of Pharmacology and Experimental Therapeutics·Kumkum GangulyVladimir R Muzykantov
May 17, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·Taher NassarAbd Al-Roof Higazi
Oct 1, 1994·Journal of Internal Medicine·H R LijnenS Thorsen
Feb 22, 2003·Blood·Chandrashekhara ManithodyAlireza R Rezaie
Aug 4, 1995·The Journal of Biological Chemistry·K Tachias, E L Madison
Dec 21, 2000·British Journal of Haematology·L A RobbieN A Booth
Nov 5, 2003·The Journal of Biological Chemistry·Catherine A IbarraJoseph D Shore
Oct 30, 2003·The Journal of Biological Chemistry·Elsa P BianchiniBernard F Le Bonniec
Jan 26, 2010·American Journal of Respiratory Cell and Molecular Biology·Taher NassarAbd Al-Roof Higazi
Sep 2, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·Galina FlorovaAndrey A Komissarov
Mar 19, 1999·Protein Science : a Publication of the Protein Society·A Vindigni, E Di Cera
May 16, 2006·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Sarah L Griffiths, David J Grainger
Aug 23, 2002·Protein Science : a Publication of the Protein Society·Thomas SulikowskiPhilip A Patston

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.